Eam Investors, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$37.49 - $63.19 $1.53 Million - $2.57 Million	-40,695 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$12.66 - $58.27 $515,198 - $2.37 Million	40,695 New	40,695 $1.9 Million
Q1 2020 May 13, 2020	SELL	$9.31 - $18.26 $491,875 - $964,730	-52,833 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$8.93 - $12.41 $96,506 - $134,114	-10,807 Reduced 16.98%	52,833 $574,000
Q3 2019 Nov 13, 2019	BUY	$8.8 - $14.5 $560,032 - $922,780	63,640 New	63,640 $654,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.